Search Results - "Wechuck, James"
-
1
Gene therapy for pain: Results of a phase I clinical trial
Published in Annals of neurology (01-08-2011)“…Objective: Preclinical evidence indicates that gene transfer to the dorsal root ganglion using replication‐defective herpes simplex virus (HSV)‐based vectors…”
Get full text
Journal Article -
2
A Clinical Trial of Gene Therapy for Chronic Pain
Published in Pain medicine (Malden, Mass.) (01-10-2009)“…ABSTRACT The first human trial of gene therapy for chronic pain, a phase 1 study of a nonreplicating herpes simplex virus (HSV)‐based vector engineered to…”
Get full text
Journal Article -
3
Herpes Simplex Virus‐Mediated Expression of Pax3 and MyoD in Embryoid Bodies Results in Lineage‐Related Alterations in Gene Expression Profiles
Published in Stem cells (Dayton, Ohio) (01-12-2008)“…The ability of embryonic stem cells to develop into multiple cell lineages provides a powerful resource for tissue repair and regeneration. Gene transfer…”
Get full text
Journal Article -
4
Construction and production of recombinant herpes simplex virus vectors
Published in Methods in molecular biology (Clifton, N.J.) (2008)“…Virus vectors have been employed as gene transfer vehicles for various pre-clinical and clinical gene therapy applications. Replication-competent herpes…”
Get more information
Journal Article -
5
Immobilized Cobalt Affinity Chromatography Provides a Novel, Efficient Method for Herpes Simplex Virus Type 1 Gene Vector Purification
Published in Journal of Virology (01-09-2004)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
6
Generation of replication-competent and -defective HSV vectors
Published in Cold Spring Harbor protocols (01-05-2011)“…Engineering effective vectors has been crucial to the efficient delivery and expression of therapeutic gene products in vivo. Among these, HSV-1 represents an…”
Get more information
Journal Article -
7
Inactivation of herpes simplex type 1 gene vector on immobilized metal affinity chromatography: Oxidative damage by hydroxyl free radicals and its prevention
Published in Biotechnology and bioengineering (05-09-2006)“…Metal catalyzed oxidation (MCO), which typically involves oxygen free radical generation, is an important pathway that leads to the deterioration of many…”
Get full text
Journal Article -
8
Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors
Published in Biotechnology and bioengineering (20-03-2002)“…Herpes simplex virus type‐1 (HSV‐1) represents a unique vehicle for the introduction of foreign DNA to cells of a variety of tissues. The nature of the vector,…”
Get full text
Journal Article -
9
Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors
Published in Biotechnology and bioengineering (05-07-2002)“…Our work uses replication‐defective genomic herpes simplex virus type‐1 (HSV‐1)‐based vectors to transfer therapeutic genes into cells of the central nervous…”
Get full text
Journal Article -
10
Evaluation of Infection Parameters in the Production of Replication-Defective HSV-1 Viral Vectors
Published in Biotechnology progress (2002)“…Herpes simplex virus type‐1 (HSV‐1) is a neurotrophic human pathogen that establishes life‐long latency in the nervous system. Our laboratory has extensively…”
Get full text
Journal Article -
11
Clinical trial links oncolytic immunoactivation to survival in glioblastoma
Published in Nature (London) (02-11-2023)“…Immunotherapy failures can result from the highly suppressive tumour microenvironment that characterizes aggressive forms of cancer such as recurrent…”
Get full text
Journal Article -
12
Delivery of herpes simplex virus-based vectors to stem cells
Published in Methods in molecular biology (Clifton, N.J.) (2004)“…In contrast to traditional drugs that generally act by altering existing gene product function, gene therapy aims to target the root cause of the disease by…”
Get more information
Journal Article -
13
-
14
Effect of Protease Inhibitors on Yield of HSV-1-Based Viral Vectors
Published in Biotechnology progress (01-05-2000)“…The ability to obtain high titer replication‐defective herpes simplex virus (HSV) recombinant vectors will dramatically affect their use in gene therapy…”
Get full text
Journal Article -
15
Herpes simplex virus-based nerve targeting gene therapy in pain management
Published in Journal of pain research (01-01-2014)“…Chronic pain represents a major medical burden not only in terms of suffering but also in terms of economic costs. Traditional medical approaches have so far…”
Get full text
Journal Article Book Review -
16
HSV-Mediated Delivery of Erythropoietin Restores Dopaminergic Function in MPTP-Treated Mice
Published in Molecular therapy (01-11-2006)“…To investigate the neuroprotective effects of erythropoietin (EPO) in a rodent model of Parkinson disease, we inoculated a nonreplicating herpes simplex…”
Get full text
Journal Article -
17
Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury
Published in Gene therapy (01-01-2009)“…Neurturin (NTN), a member of glial cell line-derived neurotrophic factor (GDNF) family, is known as an important neurotrophic factor for penis-projecting…”
Get full text
Journal Article -
18
355. A Platform for Gene Delivery to Embryonic Stem Cells Using HSV
Published in Molecular therapy (01-05-2006)“…Embryonic development is a complex process involving integrated pathways directing the ordered proliferation, migration, and differentiation of stem cells into…”
Get full text
Journal Article -
19
Multiple Applications For Replication‐Defective Herpes Simplex Virus Vectors
Published in Stem cells (Dayton, Ohio) (01-01-2001)“…Herpes simplex virus (HSV) is a neurotropic DNA virus. The viral genome is large (152 kb), and many genes are dispensable for viral function, allowing…”
Get full text
Journal Article -
20
1071. Development and Characterization of HSV-1 Vector-Expressed Dominant Negative PKC epsilon for Pain Therapy
Published in Molecular therapy (01-05-2006)“…The vanilloid receptor (TRPV1) is an important pro-nociceptive Ca+2 channel, the inhibition of which attenuates pain. Recent studies have shown that TRPV1…”
Get full text
Journal Article